Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InfuSystems Holdings, Inc. (INFU : AMEX)

• Company Description    InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management. Number of Employees: 514

• Price / Volume Information    Yesterday's Closing Price: $6.19 Daily Weekly Monthly 20 Day Moving Average: 273,619 shares Shares Outstanding: 21.02 (millions) Market Capitalization: $130.09 (millions) Beta: 1.81 52 Week High: $9.97 52 Week Low: $4.61 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.48% -2.32% 12 Week 26.07% 6.04% Year To Date -26.75% -31.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3851 West Hamlin Road - Rochester Hills,MI 48309 USA ph: 248-291-1210 fax: 800-455-4338 None http://www.infusystem.com

• General Corporate Information    Officers Richard DiIorio - Chief Executive Officer and Director Scott Shuda - Chairman Carrie Lachance - President and Chief Operating Officer Barry Steele - Chief Financial Officer Kenneth Eichenbaum - Director Peer Information InfuSystems Holdings, Inc. (BJCT) InfuSystems Holdings, Inc. (CADMQ) InfuSystems Holdings, Inc. (APNO) InfuSystems Holdings, Inc. (UPDC) InfuSystems Holdings, Inc. (IMTIQ) InfuSystems Holdings, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45685K102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 21.02 Most Recent Split Date: (:1) Beta: 1.81 Market Capitalization: $130.09 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.06 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: 103.17 Trailing 12 Months: 44.21 PEG Ratio: - Price Ratios Price/Book: 2.36 Price/Cash Flow: 8.82 Price / Sales: 0.95 EPS Growth vs. Year Ago Period: 80.00% vs. Previous Quarter: -125.00% Sales Growth vs. Year Ago Period: 8.50% vs. Previous Quarter: 2.56% ROE 06/30/25 - - 03/31/25 - 5.76 12/31/24 - 4.29 ROA 06/30/25 - - 03/31/25 - 3.03 12/31/24 - 2.22 Current Ratio 06/30/25 - - 03/31/25 - 2.21 12/31/24 - 1.82 Quick Ratio 06/30/25 - - 03/31/25 - 1.83 12/31/24 - 1.45 Operating Margin 06/30/25 - - 03/31/25 - 2.32 12/31/24 - 1.74 Net Margin 06/30/25 - - 03/31/25 - 2.32 12/31/24 - 1.74 Pre-Tax Margin 06/30/25 - - 03/31/25 - 4.80 12/31/24 - 3.75 Book Value 06/30/25 - - 03/31/25 - 2.62 12/31/24 - 2.71 Inventory Turnover 06/30/25 - - 03/31/25 - 9.86 12/31/24 - 9.80 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.52 12/31/24 - 0.41 Debt-to-Capital 06/30/25 - - 03/31/25 - 34.23 12/31/24 - 29.32

Powered by Zacks Investment Research ©